Prophylaxis for cytomegalovirus in pancreas transplant recipients using intravenous ganciclovir.
Kohli
V
V
Mayo Clinic, Rochester, MN 55905, USA.
Velosa
J
J
Sterioff
S
S
Munn
S R
SR
D000328:Adult; D000961:Antilymphocyte Serum / Q000008:administration & dosage / Q000009:adverse effects; D003586:Cytomegalovirus Infections / Q000209:etiology / Q000517:prevention & control*; D005260:Female; D015774:Ganciclovir / Q000008:administration & dosage*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects; D007275:Injections, Intravenous; D008297:Male; D016035:Pancreas Transplantation / Q000009:adverse effects*; D012189:Retrospective Studies
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D015774:Ganciclovir